EBD GmbH is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® 2016 Press Releases

February 2, 2016BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016. Organized by EBD Group, the event is co-hosted by Stockholm Business Region and Stockholm Science City Foundation. The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of ...  more ►

July 30, 2015Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►


partnering360® Blog

February 8, 2016 Top 10 Digital Health Trends: Implications for Early to Mid-Stage Biopharma Guest post by Jay Goldman (Managing Director, Sensei Labs at Klick Health) and Michael W. Young (VP, Strategy at Klick Health) We recently had the pleasure of presenting on the Top 10 Digital Health Trends at Biotech Showcase™ 2016’s inaugural Digital Health Showcase. Our highly engaged audience... more ►

February 4, 2016 Can biology, even drug discovery, be “clouded”? It’s early but Andreessen Horowitz VC thinks so Digital health is not just a buzzword in the life science industry; it is an innovative, potentially disruptive, health paradigm that is gaining momentum. At Digital Health Showcase in January, CBT Advisors’ Steve Dickman met with Vijay Pande of Andreessen Horowitz, a renowned professor formerly... more ►

February 2, 2016 Where you build your healthcare IP is just as important as how you build it Guest post by Ben Ball, Business Development Manager, Australian Consulate-General   For most businesses, intellectual property is the foundation you build on. Transforming an idea into a product is only half the battle—the way you take that product to market may ultimately play a larger part... more ►

January 27, 2016 Why do we believe in Nordic life science? Guest post by Anna Sandström, Science Relations Director, AstraZeneca   While my high-speed train whirls its way across the broadest part of Sweden, from Gothenburg to Stockholm I am finishing my dinner, and as I lift the glass I once again start to philosophize about why some people tend to... more ►

January 22, 2016 Golden Ticket winner represents partnering opportunities with academia   We are proud to have sponsored the Circus before the Circus networking reception at the Four Seasons Hotel on January 10 during healthcare’s busiest week in San Francisco. Biotech Showcase™ 2016 investor and networking conference—the event where innovation meets money—broke records... more ►



partnering360:Insight Latest headlines from partnering360:Insight

January 19, 2016 Digital Health Showcase: State of the Industry Report Digital health is a young, vibrant industry with great potential. Now, after five years of buzz, it’s beginning to deliver on that potential with opportunities for drug developers, clinicians and patients, according to speakers at Digital Health Showcase, held in conjunction with Biotech Showcase™ 2016 January 13 in San Francisco. more ►

January 19, 2016 Bubble trouble? Investors advise cautious optimism Biotech still outperforms the S&P, attracts new investors and has a healthy pipeline. The fundamentals are still there. That’s why investment veterans speaking at the Biotech Showcase 2016 luncheon plenary January 13 in San Francisco remain optimistic despite advising CEOs to prepare for a downturn. more ►

January 19, 2016 Digital health and big pharma: A tale of two companies Digital health strategies have the potential to increase patient compliance and monitor and manage disease progression. For big pharma, they offer a way to improve patient experiences and gain deeper insights that may support outcomes-based pricing, according to experts from Novartis and Takeda Pharmaceuticals International, speaking at Digital Health Showcase January 13, held concurrently with Biotech Showcase™ 2016 in San Francisco. more ►

January 13, 2016 Medtech Showcase: State of the Industry 2016 Healthcare is converging, bringing together traditional therapeutics, precision medicine, combination products and companion diagnostics that require insightful approval and reimbursement policies. It also requires that entrepreneurs develop a keen understanding of what drives their potential markets, according to speakers at Medtech Showcase, held January 12 in San Francisco in concert with Biotech Showcase 2016. more ►

January 12, 2016 Panel points fingers at insurance industry and healthcare complexity for high costs A sound-bite culture, a devious insurance industry and a complicit media are why the pharmaceutical industry has an approval rating lower than the US Congress, according to speakers at “The Great Pricing Debate,” Monday’s luncheon plenary at Biotech Showcase January 11 in San Francisco. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use